Search

Hazel Sidberry

Examiner (ID: 3280)

Most Active Art Unit
1813
Art Unit(s)
1641, 1802, 1806, 1813
Total Applications
263
Issued Applications
103
Pending Applications
37
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
07/540261 METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF SHIPPING FEVER Jun 17, 1990 Abandoned
07/537454 PASTEURELLA MULTOCIDA TOXOID VACCINES Jun 12, 1990 Abandoned
07/536096 POLYPEPTIDES AND POLYPEPTIDE ANALOGUES Jun 7, 1990 Abandoned
Array ( [id] => 3061148 [patent_doc_number] => 05352450 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop' [patent_app_type] => 1 [patent_app_number] => 7/529602 [patent_app_country] => US [patent_app_date] => 1990-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9520 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352450.pdf [firstpage_image] =>[orig_patent_app_number] => 529602 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/529602
Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop May 28, 1990 Issued
07/511869 VACCINE, ANTIBODIES & ANTIBODY-CONTAINING COMPOSITIONS FOR INHIBITING HUMAN DENTAL CAVITIES INDUCED BY STREPTOCOCCUS MUTANS Apr 17, 1990 Abandoned
07/504850 COMPOSITIONS AND TREATMENTS FOR PNEUMONIA IN ANIMALS Apr 4, 1990 Abandoned
Array ( [id] => 3700425 [patent_doc_number] => 05677438 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Coccidiosis vaccine' [patent_app_type] => 1 [patent_app_number] => 7/500162 [patent_app_country] => US [patent_app_date] => 1990-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 8828 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677438.pdf [firstpage_image] =>[orig_patent_app_number] => 500162 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/500162
Coccidiosis vaccine Mar 26, 1990 Issued
07/487716 ANTIGENIC PROTEIN OF BORRELLIA BURGDORFERI Mar 4, 1990 Abandoned
07/472319 MEROSIN, NUCLEIC ACIDS ENCODING, FRAGMENTS AND USES THEREOF Jan 29, 1990 Abandoned
07/470637 VACCINES AGAINST CANCER AND INFECTIOUS DISEASES Jan 25, 1990 Abandoned
07/466577 TUMOR KILLING EFFECTS OF ENTEROTOXINS AND RELATED COMPOUNDS Jan 16, 1990 Abandoned
07/459635 TARGET-SPECIFIC CYTOTOXIC, RECOMBINANT PSEUDOMONAS EXOTOXIN Jan 1, 1990 Abandoned
Array ( [id] => 2974889 [patent_doc_number] => 05194596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-16 [patent_title] => 'Production of vascular endothelial cell growth factor' [patent_app_type] => 1 [patent_app_number] => 7/450883 [patent_app_country] => US [patent_app_date] => 1989-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20602 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/194/05194596.pdf [firstpage_image] =>[orig_patent_app_number] => 450883 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/450883
Production of vascular endothelial cell growth factor Dec 13, 1989 Issued
Array ( [id] => 2940572 [patent_doc_number] => 05223426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-29 [patent_title] => 'Monoclonal antibodies reactive with defined regions of the T-cell antigen receptor' [patent_app_type] => 1 [patent_app_number] => 7/449692 [patent_app_country] => US [patent_app_date] => 1989-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 23 [patent_no_of_words] => 28792 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/223/05223426.pdf [firstpage_image] =>[orig_patent_app_number] => 449692 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/449692
Monoclonal antibodies reactive with defined regions of the T-cell antigen receptor Dec 10, 1989 Issued
07/435897 VACCINES OBTAINED FROM ANTIGENIC GENE PRODUCTS OF RECOMBINANT GENES Nov 12, 1989 Abandoned
07/428956 PREPARATIONS ACTIVE AGAINST PSEUDOMONAS AERUGINOSA INFECTIONS AND METHODS OF PRODUCING THEM Oct 29, 1989 Abandoned
07/422881 BORRELIA ANTIGEN Oct 17, 1989 Abandoned
07/416530 TUMOR KILLING EFFECTS OF ENTEROTOXINS Oct 2, 1989 Abandoned
Array ( [id] => 2955690 [patent_doc_number] => 05231168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-27 [patent_title] => 'Malaria antigen' [patent_app_type] => 1 [patent_app_number] => 7/409658 [patent_app_country] => US [patent_app_date] => 1989-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 30219 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/231/05231168.pdf [firstpage_image] =>[orig_patent_app_number] => 409658 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/409658
Malaria antigen Sep 17, 1989 Issued
Array ( [id] => 2938887 [patent_doc_number] => 05254340 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-19 [patent_title] => 'Vaccine suitable for prophylaxis and control, respectively, of the pig disease caused by Haemophilus pleuropneumoniae and a method for obtaining extracellular proteinaceous material of Haemophilus pleuropneumoniae for use in such vaccines' [patent_app_type] => 1 [patent_app_number] => 7/392781 [patent_app_country] => US [patent_app_date] => 1989-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4145 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/254/05254340.pdf [firstpage_image] =>[orig_patent_app_number] => 392781 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/392781
Vaccine suitable for prophylaxis and control, respectively, of the pig disease caused by Haemophilus pleuropneumoniae and a method for obtaining extracellular proteinaceous material of Haemophilus pleuropneumoniae for use in such vaccines Aug 10, 1989 Issued
Menu